141 related articles for article (PubMed ID: 35265689)
1. Physical Inactivity Is Associated With Post-discharge Mortality and Re-hospitalization Risk Among Swedish Heart Failure Patients-The HARVEST-Malmö Study.
Zaghi A; Holm H; Korduner J; Dieden A; Molvin J; Bachus E; Jujic A; Magnusson M
Front Cardiovasc Med; 2022; 9():843029. PubMed ID: 35265689
[TBL] [Abstract][Full Text] [Related]
2. The impact of myocardial fibrosis biomarkers in a heart failure population with atrial fibrillation-The HARVEST-Malmö study.
Nezami Z; Holm H; Ohlsson M; Molvin J; Korduner J; Bachus E; Zaghi A; Dieden A; Platonov PG; Jujic A; Magnusson M
Front Cardiovasc Med; 2022; 9():982871. PubMed ID: 36337899
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular biomarkers predict post-discharge re-hospitalization risk and mortality among Swedish heart failure patients.
Molvin J; Jujic A; Bachus E; Gallo W; Tasevska-Dinevska G; Holm H; Melander O; Fedorowski A; Magnusson M
ESC Heart Fail; 2019 Oct; 6(5):992-999. PubMed ID: 31339668
[TBL] [Abstract][Full Text] [Related]
4. Clinical characteristics of hospitalized heart failure patients with preserved, mid-range, and reduced ejection fractions in Japan.
Shiga T; Suzuki A; Haruta S; Mori F; Ota Y; Yagi M; Oka T; Tanaka H; Murasaki S; Yamauchi T; Katoh J; Hattori H; Kikuchi N; Watanabe E; Yamada Y; Haruki S; Kogure T; Suzuki T; Uetsuka Y; Hagiwara N;
ESC Heart Fail; 2019 Jun; 6(3):475-486. PubMed ID: 30829002
[TBL] [Abstract][Full Text] [Related]
5. Impact of Physical Inactivity on Mortality in Patients With Heart Failure.
Doukky R; Mangla A; Ibrahim Z; Poulin MF; Avery E; Collado FM; Kaplan J; Richardson D; Powell LH
Am J Cardiol; 2016 Apr; 117(7):1135-43. PubMed ID: 26853954
[TBL] [Abstract][Full Text] [Related]
6. Serum aldosterone is associated with mortality and re-hospitalization in patients with reduced ejection fraction hospitalized for acute heart failure: analysis from the EVEREST trial.
Girerd N; Pang PS; Swedberg K; Fought A; Kwasny MJ; Subacius H; Konstam MA; Maggioni A; Gheorghiade M; Zannad F;
Eur J Heart Fail; 2013 Nov; 15(11):1228-35. PubMed ID: 23787720
[TBL] [Abstract][Full Text] [Related]
7. Community-based care for the specialized management of heart failure: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2009; 9(17):1-42. PubMed ID: 23074521
[TBL] [Abstract][Full Text] [Related]
8. Soluble neprilysin is predictive of cardiovascular death and heart failure hospitalization in heart failure patients.
Bayés-Genís A; Barallat J; Galán A; de Antonio M; Domingo M; Zamora E; Urrutia A; Lupón J
J Am Coll Cardiol; 2015 Feb; 65(7):657-65. PubMed ID: 25677426
[TBL] [Abstract][Full Text] [Related]
9. The Hospitalization Burden and Post-Hospitalization Mortality Risk in Heart Failure With Preserved Ejection Fraction: Results From the I-PRESERVE Trial (Irbesartan in Heart Failure and Preserved Ejection Fraction).
Carson PE; Anand IS; Win S; Rector T; Haass M; Lopez-Sendon J; Miller A; Teerlink JR; White M; McKelvie RS; Komajda M; Zile MR; McMurray JJ; Massie B
JACC Heart Fail; 2015 Jun; 3(6):429-441. PubMed ID: 25982110
[TBL] [Abstract][Full Text] [Related]
10. Anemia and associated clinical outcomes in patients with heart failure due to reduced left ventricular systolic function.
McCullough PA; Barnard D; Clare R; Ellis SJ; Fleg JL; Fonarow GC; Franklin BA; Kilpatrick RD; Kitzman DW; O'Connor CM; Piña IL; Thadani U; Thohan V; Whellan DJ;
Clin Cardiol; 2013 Oct; 36(10):611-20. PubMed ID: 23929781
[TBL] [Abstract][Full Text] [Related]
11. Heart failure hospitalization: An important prognostic factor for heart failure re-admission and mortality.
Ruigómez A; Michel A; Martín-Pérez M; García Rodríguez LA
Int J Cardiol; 2016 Oct; 220():855-61. PubMed ID: 27400184
[TBL] [Abstract][Full Text] [Related]
12. Pre-discharge and early post-discharge troponin elevation among patients hospitalized for heart failure with reduced ejection fraction: findings from the ASTRONAUT trial.
Greene SJ; Butler J; Fonarow GC; Subacius HP; Ambrosy AP; Vaduganathan M; Triggiani M; Solomon SD; Lewis EF; Maggioni AP; Böhm M; Chioncel O; Nodari S; Senni M; Zannad F; Gheorghiade M;
Eur J Heart Fail; 2018 Feb; 20(2):281-291. PubMed ID: 29044915
[TBL] [Abstract][Full Text] [Related]
13. Galectin-4 levels in hospitalized versus non-hospitalized subjects with obesity: the Malmö Preventive Project.
Korduner J; Holm H; Jujic A; Melander O; Pareek M; Molvin J; Råstam L; Lindblad U; Daka B; Leosdottir M; Nilsson PM; Bachus E; Olsen MH; Magnusson M
Cardiovasc Diabetol; 2022 Jul; 21(1):125. PubMed ID: 35780152
[TBL] [Abstract][Full Text] [Related]
14. Association between diabetes mellitus and post-discharge outcomes in patients hospitalized with heart failure: findings from the EVEREST trial.
Sarma S; Mentz RJ; Kwasny MJ; Fought AJ; Huffman M; Subacius H; Nodari S; Konstam M; Swedberg K; Maggioni AP; Zannad F; Bonow RO; Gheorghiade M;
Eur J Heart Fail; 2013 Feb; 15(2):194-202. PubMed ID: 23059198
[TBL] [Abstract][Full Text] [Related]
15. Physical Activity and Prognosis in the TOPCAT Trial (Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist).
Hegde SM; Claggett B; Shah AM; Lewis EF; Anand I; Shah SJ; Sweitzer NK; Fang JC; Pitt B; Pfeffer MA; Solomon SD
Circulation; 2017 Sep; 136(11):982-992. PubMed ID: 28637881
[TBL] [Abstract][Full Text] [Related]
16. Predictors of mortality after discharge in patients hospitalized with heart failure: an analysis from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF).
O'Connor CM; Abraham WT; Albert NM; Clare R; Gattis Stough W; Gheorghiade M; Greenberg BH; Yancy CW; Young JB; Fonarow GC
Am Heart J; 2008 Oct; 156(4):662-73. PubMed ID: 18926148
[TBL] [Abstract][Full Text] [Related]
17. Association of Hospital Performance Based on 30-Day Risk-Standardized Mortality Rate With Long-term Survival After Heart Failure Hospitalization: An Analysis of the Get With The Guidelines-Heart Failure Registry.
Pandey A; Patel KV; Liang L; DeVore AD; Matsouaka R; Bhatt DL; Yancy CW; Hernandez AF; Heidenreich PA; de Lemos JA; Fonarow GC
JAMA Cardiol; 2018 Jun; 3(6):489-497. PubMed ID: 29532056
[TBL] [Abstract][Full Text] [Related]
18. Association of Fibroblast Growth Factor 23 With Recurrent Cardiovascular Events in Patients After an Acute Coronary Syndrome: A Secondary Analysis of a Randomized Clinical Trial.
Bergmark BA; Udell JA; Morrow DA; Cannon CP; Steen DL; Jarolim P; Budaj A; Hamm C; Guo J; Im K; Kuder JF; Braunwald E; Sabatine MS; O'Donoghue ML
JAMA Cardiol; 2018 Jun; 3(6):473-480. PubMed ID: 29710336
[TBL] [Abstract][Full Text] [Related]
19. Exercise-based cardiac rehabilitation for chronic heart failure: the EXTRAMATCH II individual participant data meta-analysis.
Taylor RS; Walker S; Ciani O; Warren F; Smart NA; Piepoli M; Davos CH
Health Technol Assess; 2019 May; 23(25):1-98. PubMed ID: 31140973
[TBL] [Abstract][Full Text] [Related]
20. Poor prognosis of heart failure patients with in-hospital worsening renal function and elevated BNP at discharge.
Okabe T; Yakushiji T; Kido T; Kimura T; Asukai Y; Shimazu S; Saito J; Oyama Y; Igawa W; Ono M; Ebara S; Yamashita K; Yamamoto MH; Amemiya K; Isomura N; Ochiai M
ESC Heart Fail; 2020 Oct; 7(5):2912-2921. PubMed ID: 32643875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
